Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ImmunoGen
Welcome,
Profile
Billing
Logout
23 Products
72 Diseases
23 Products
169 Trials
6343 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
17
34
51
68
85
102
119
136
153
170
Kadcyla
(ado-trastuzumab emtansine) / Roche
Sarclisa
(isatuximab-irfc) / Sanofi
Elahere
(mirvetuximab soravtansine-gynx) / AbbVie
anetumab ravtansine
(BAY 94-9343) / Bayer
tusamitamab ravtansine
(SAR408701) / Sanofi, AbbVie
VRDN-001
/ Viridian Therap
lorvotuzumab mertansine
(IMGN901) / AbbVie
coltuximab ravtansine
(SAR3419) / AbbVie
pivekimab sunirine
(IMGN632) / Jazz
SAR566658
/ Sanofi, AbbVie
indatuximab ravtansine
(BT-062) / Grifols
cantuzumab ravtansine
(IMGN242) / AbbVie
izeltabart tapatansine
(IMGC936) / MacroGenics, AbbVie
naratuximab emtansine
(DEBIO 1562) / Debiopharm
praluzatamab ravtansine
(CX-2009) / CytomX, AbbVie
AMG 595
/ AbbVie
AVE9633
/ Sanofi
IMGN388
/ AbbVie
IMGN779
/ Jazz
LY3076226
/ Eli Lilly
SAR428926
/ Sanofi
TAK-164
/ Takeda
laprituximab emtansine
(IMGN289) / AbbVie
opugotamig olatansine
(IMGN-151) / AbbVie
